Global Digital Pathology Market Size, Growth, Opportunity and Forecast 2022-2030

  • Product Code:
    RP-ID-10008191
  • Published Date:
    2 Dec 2021
  • Region:
    Global
  • Pages:
    140
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-12

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

"The global digital pathology market is estimated to be worth ~USD 900 million by the end of 2021, and it is expected to expand at a compound annual growth rate (CAGR) of 7% from 2022 to 2030. Chronic diseases. Diseases such as cancer have always been key factors driving growth. The increasing prevalence of chronic diseases is expected to increase the clinical urgency of using digital pathology to improve existing patients ; poor imaging measures and reduce the high costs associated with traditional diagnosis.


 During COVID-19, the U.S. FDA Center for Devices and Radiological Health issued a compliance policy for remote digital pathology equipment applicable to pathologists, industry, clinical laboratories, drug managers, and medical institutions. This document provides a policy framework for expanding the availability of remote digital pathology equipment during a pandemic. 

 

The supporting regulations are expected to have a positive impact on the market in the next few years, and the rapid technological advancement of digital pathology systems is expected to promote market growth. Advances in digital imaging, computerization, robotic optical microscopes, and multi-fiber communications have also contributed to growth. Full slice imaging is a technology with many advantages compared with traditional optical microscopes, and it is expected to bring profitable opportunities to this market in the next few years. In addition, advancements such as microarrays and the combination of broad predictive models such as hybrid models and API algorithms are expected to drive the demand for digital image analysis. 


The increasing popularity of computer-aided diagnosis that integrates image processing, physics, mathematics, and computer algorithms promotes effective disease detection, and helps to assess anatomical structures of interest, quantify disease progression, and assess risk. These benefits are expected to drive the demand for digital pathology systems in the near future. 


The new coronavirus has had a significant economic impact on most industries, including the healthcare industry. Government agencies around the world are responding to the COVID-19 threat through basic measures such as nationwide lockdowns, social distancing, and mass quarantine to reduce the spread of the virus. The pandemic has created tremendous growth opportunities for digital pathology. 

 

On March 26, 2020, CMS temporarily cancelled the strict regulations on remote diagnosis and allowed the use of digital pathology equipment to remotely close pathology cases. Used for remote slide sharing and image processing, it is expected to increase the adoption rate in the next few years. In April 2020, Leica Biosystems obtained the US FDAs Aperio AT2 DX Scanner and Aperio WebViewer licenses for remote diagnosis during a pandemic. In addition, Phillips has also obtained a license from the US Food and Drug Administration (USFDA) for the IntelliSite pathology solution for remote diagnosis in this emergency situation.

 

 PRODUCT INSIGHT: 


 The equipment division dominates the digital pathology market, with the largest revenue share in 2020 at 50%. The equipment includes a scanner and a slide management system. Increasing academic research activities and improving resolution are key drivers of growth. Thanks to advances in zoom and Z-axis slide scanning provided in full slide imaging, this technology is expected to achieve profitable growth during the forecast period.


In addition, the increase in the use of scanners in pathology laboratories has further promoted market growth. It is expected that in the near future, research and development related to applications such as the slide manager will promote the adoption of this technology. The growing demand for online storage systems has further fueled the growth. It is expected that advantages such as reduced costs, increased productivity, and better patient outcomes, as well as data reliability and image lifecycle management (ILM), will drive market development.

 

APPLICATION INSIGHT : 


The academic research department leads the digital pathology market and will have the largest revenue share in 2020, at 44%. This growth is driven by the widespread use of the system in various research procedures, such as biomarker profiling and morphological research. Due to the increase in the prevalence of chronic diseases, the disease diagnosis part is expected to have the fastest compound annual growth rate of 7.0% during the forecast period. In addition, manufacturers focus on the development of novel and rapid diagnostic techniques. 


Digital technology helps to improve every step of the diagnosis and promotes the exchange of information within or within the department. Due to the high prevalence of the disease and ongoing research projects, it is expected that the cancer cell detection part will show a profitable growth in the disease diagnosis part in the prophase.

 

REGIONAL INFORMATION: 


In 2020, North America dominated the digital pathology market, with the largest revenue share, exceeding 41%. The continuous deployment of R&D investment, government support measures related to the development of technologically advanced systems, the increasing adoption of digital images, and the presence of important players are the key factors contributing to this field. 


Increasing use of digital pathology for disease diagnosis, coupled with favorable reimbursement policies in the United States, has improved the quality of cancer diagnosis and is expected to further promote regional growth. 

 

Due to the increasing penetration rate of digital imaging in emerging economies, investment in the medical field, and untapped opportunities, it is 7% during the forecast period. Due to the increasing incidence of cancer and affecting a large number of people, the healthcare industry in the Asia-Pacific region has had a great impact on the market. In addition, the growing demand for new treatment options, improved patient care facilities, and lower laboratory costs is expected to further drive demand.

 

MAJOR COMPANIES AND MARKET SHARE PROSPECTS : 


Danaher and other major players; Hamamatsu Optoelectronics; Occupy dominant market share in 2020. These companies are increasingly embarking on new product development, extensive cooperation strategies and mergers and acquisitions to obtain more profits. 

 

For example, in August 2020, Danaher launched the Aperio GT 450 DX in Europe, and in May, the product was launched in the Asia-Pacific region. These strategic products launched in new regions aim to improve the company's regional footprint. In September 2020, another major participant, Koninklijke Philips N.V.. helped 100% digitize histological sections in the Department of Cell Pathology of Oxford University Hospital. In addition, in June 2018, it acquired one of the largest pathology imaging analysis companies, PathXL, Ireland.


 The acquisition aims to develop integrated tools for computational biology, workflow solutions, education and image analysis applications. This acquisition aims to support the gradual transition of global medical institutions from traditional systems to digital pathology systems. 


Therefore, this acquisition will enable pathologists to perform high-throughput analysis of large and diverse clinical image data sets and help improve the quality of diagnosis, making it possible to adopt new therapies to improve the health of patients. Some of the major players in the digital pathology market include: DanaherHamamatsu Photonics, Inc. Koninklijke Philips N.V. Olympus Corporation F. Hoffmann-La Roche Ltd. Mikroscan Technologies Inspirata, Inc.Visiopharm A / SHuron Digital Pathology 3DHISTECH Ltd.ContextVision AB."
 


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

1. Leica Biosystems
2. Ventana Medical Systems
3. Hamamatsu Photonics
4. 3DHISTECH
5. Koninklijke Philips
6. Apollo Enterprise Imaging
7. XIFIN
8. Huron Digital Pathology
9. Visiopharm
10. Corista
11. Indica Labs
12. Objective Pathology Services

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports